| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0004 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.0006 |
| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.17 |
0.0007 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0008 |